Mergers & Acquisitions - G2 Intelligence

Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

Start a Free Trial for immediate access to this article

Already a member? Log in here

As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.

Start a Free Trial for immediate access to this article

Already a member? Log in here

The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.

Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.

Start a Free Trial for immediate access to this article

Already a member? Log in here